Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2003;42:656
Published online before print September 29, 2003, doi: 10.1161/01.HYP.0000094242.32778.9B
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
42/4/656    most recent
01.HYP.0000094242.32778.9Bv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

(Hypertension. 2003;42:656.)
© 2003 American Heart Association, Inc.


Awards

2003 IASH Lifetime Achievement Award


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

DownCarlos M. Ferrario, M.D., is an Argentine-born cardiologist whose research has advanced understanding and treatment of high blood pressure and vascular disease. A graduate of the University of Buenos Aires Medical School in 1963, Dr Ferrario pursued postgraduate training in cardiology at the University of Göteborg and the Karolinska Institute in Sweden between 1964 and 1966.


Figure Removed (Available Only in the Full Text)
View larger version (133K):
[in this window]
[in a new window]
 

Dr Ferrario joined Dr Irvine H. Page, a pioneer in hypertension research, at The Cleveland Clinic Foundation in 1966. Under his mentorship, Dr Ferrario developed a premier program on the neural and endocrine causes of hypertension. Dr Ferrario chaired the Department of Brain and Vascular Research of the Cleveland Clinic Foundation from 1984 to 1992. He assumed the directorship of the Hypertension and Vascular Disease Center of the Wake Forest University School of Medicine in 1992 and founded the Consortium for Southeastern Hypertension Control (COSEHC).

Dr Ferrario’s research has encompassed multiple areas of hypertension, including the central nervous system actions of angiotensin, the role of the sympathetic nervous system in cardiac hypertrophy, new pathways for formation of angiotensin peptides, and the functions of angiotensin-(1-7). His recent studies on the role of the renin angiotensin system in the pathogenesis of atherosclerosis has lead to increased understanding of the interaction between lipids and endocrine hormones in the evolution of atherosclerosis.

Dr Ferrario has published over 385 papers and 2 books and has mentored many physicians who have become medical leaders in the United States, Japan, and Latin America. He has served as president of the Inter-American . . . [Full Text of this Article]